News

Institutional news
<p>Tàndem Schools</p>
18 Jun 2018

The new school lab has come about from the Escuelas Tándem (Tandem Schools) project, which is supported by IRB Barcelona and the Catalunya La Pedrera Foundation.

The Montserrat School and IRB Barcelona have just brought the Tandem Schools Project to a close. This educational initiative has applied science as a core theme to enhance the innovative activities, academic results, prestige, and social cohesion of the school.

Run and financed by the Catalunya La Pedrera Foundation, the project is one of the first tandems between a primary school and a scientific institute.

Institutional news
<p>Travis Stracker, Renata Basto and Jens Lüders, organizers of the BioMed Conference</p>
11 Jun 2018

A conference organised by IRB Barcelona and the BBVA Foundation brings together leading international researchers devoted to two cell organelles that play key roles in health and disease.

Cancer and certain developmental disorders are characterised by impaired activity of these complex cell structures and defects in cell cycle control.

Institutional news
8 Jun 2018

The Asociación Española Contra el Cáncer (AECC) presents a prize for a study that reveals the capacity of the CPEB4 protein to prevent fatty liver disease.

The research was led by Raúl Méndez from IRB Barcelona and Mercedes Fernández from IDIBAPS.

Institutional news
5 Jun 2018

This weekend the Ciutadella Park will be hosting this event, which will showcase 230 scientific activities aimed at the general public.

IRB Barcelona will be participating through two workshops and a micro-talk, related to microscopy, cancer research and ageing.

Institutional news
<p>Jordi Casanova, head of the Development and Morphogenesis in Drosophila Lab at IRB Barcelona</p>
1 Jun 2018

Jordi Casanova from IRB Barcelona wrote an opinion article in EMBO Journal.

The author highlights that scientists should be aware of the limitations of models and categories.
 

Institutional news
<p>Travis Stracker, head of the Genomic Instability and Cancer lab at IRB Barcelona</p>
30 May 2018

The video series Meet Our Scientists presents Travis Stracker, head of the Genomic Instability and Cancer lab at IRB Barcelona.

The video “Maintaining stability of the genome” highlights the research underway to unravel how cells prevent genomic instability.

Scientific news
<p>Image of breast cancer cells derived from a mouse mammary tumour (in blue: nucleus, in green: tubulin) Author: Begoña Cánovas, IRB Barcelona</p>
24 May 2018

A study on breast cancer conducted at IRB Barcelona identifies the key role of p38 in safeguarding tumour cells against the excessive accumulation of DNA damage, which would otherwise cause cell death.

p38 blockage has been shown to increase the death of tumour cells, thus causing tumours to shrink.

The combination of p38 inhibitors with chemotherapeutic drugs (taxanes) strengthens, accelerates or prolongs the antitumour effect in patient-derived tumours grown in mice.

Scientific news
<p>The graphic shows a new class of prolyl oligopeptidase (POP) inhibitor. The inhibitor is able to reach the brain and bind to the POP protein, In yellow/red, the reactive group of the inhibitor that bind to the catalytic site of the protein (S Guardiola)</p>
17 May 2018

For the scientific community, the protein POP (prolyl oligopeptidase) is an attractive therapeutic target for the treatment of cognitive and neurodegenerative disorders.

Scientists at IRB Barcelona have developed the first POP inhibitors that are irreversible, selective and brain-permeable.

Institutional news
<p>Salvador Aznar Benitah leads the Stem cells and cancer lab at IRB Barcelona. In the picture he is seen Gloria Pascual, research associate in the same lab (M Minocri, IRB Barcelona)</p>
14 May 2018

Nine scientists at IRB Barcelona form part of EMBO, an organisation that comprises more than 1,800 outstanding researchers from Europe and around the world specialised in molecular biology.

“This will allow me to strengthen interactions with other European researchers, as well as to stay abreast of new ideas, concepts and technologies,” says Aznar Benitah.

Institutional news
<p>Guiomar Solanas, research associate at the Stem Cells and Cancer Lab</p>
11 May 2018

BIST has selected 12 winners, among them Guiomar Solanas, Jelena Urosevic and Lidia Mateo.

This programme recognises excellence in research and supports women scientists in their transition to leadership positions.